FRX - Forest Laboratories Inc. patents

This listing is of recent patents (patent applications) which may be related to Forest Laboratories Inc. according to a patent app search. In *most* cases, they are listed under Forest Laboratories Inc. because the company is listed in the Agent field of the patent application. Note: Forest Laboratories Inc. (FRX) may have other listings under a different name, spelling or agent. If there is another company with a similar name, it's possible their patents could be inadvertantly included here. Notify us of any issues. Also, FreshPatents.com is not affiliated with Forest Laboratories Inc., we're just tracking patents related to them as published publically by the USPTO. Full list of Stock Symbols and Company RSS Feeds

SUBSCRIBE to updates on this page: Forest Laboratories Inc. patents RSS Feed (FREE)

F

FAF
F
FEIC
FISI
FMC
FOE
FORM
FRX

Symbol	Company	Application #	Date	Title
FRX	Forest Laboratories	20120010180	20120112	Soluble dosage forms containing cephem derivatives suitable for parenteral administration
FRX	Forest Laboratories	20120004318	20120105	Modified release formulations of memantine oral dosage forms
FRX	Forest Laboratories	20120004213	20120105	Novel piperazine derivatives as inhibitors of stearoyl-coa desaturase
FRX	Forest Laboratories	20110245254	20111006	Heterocyclic compounds as inhibitors of beta-lactamases
FRX	Forest Laboratories	20110236439	20110929	Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane
FRX	Forest Laboratories	20110165252	20110707	Memantine formulations
FRX	Forest Laboratories	20110144210	20110616	Stable dosage forms of levomilnacipran
FRX	Forest Laboratories	20110112197	20110512	Novel crystalline forms of (1s,2r)-2-(amino methyl)-n,n-diethyl-1-phenyl cyclopropane carboxamide
FRX	Forest Laboratories	20110071114	20110324	Compositions and methods for treating bacterial infections using ceftaroline
FRX	Forest Laboratories	20110059903	20110310	Formulations comprising linaclotide
FRX	Forest Laboratories	20110046232	20110224	Orally dissolving formulations of memantine
FRX	Forest Laboratories	20110046134	20110224	Novel piperazine derivatives as inhibitors of stearoyl-coa desaturase
FRX	Forest Laboratories	20110028722	20110203	Novel solvate and crystalline forms of carbamoyl-cyclohexane derivatives
FRX	Forest Laboratories	20110015208	20110120	Pharmaceutical compositions containing dopamine receptor ligands and methods of treatment using dopamine receptor ligands
FRX	Forest Laboratories	20100286260	20101111	Milnacipran formulations
FRX	Forest Laboratories	20100280067	20101104	Inhibitors of acetyl-coa carboxylase
FRX	Forest Laboratories	20100240611	20100923	Methods for preparing dpp-iv inhibitor compounds
FRX	Forest Laboratories	20100216745	20100826	Novel cephem compounds useful for the treatment of bacterial infections
FRX	Forest Laboratories	20100197650	20100805	Compositions and methods of treatment comprising ceftaroline
FRX	Forest Laboratories	20100197797	20100805	Methods of managing fibromyalgia using milnacipran
FRX	Forest Laboratories	20100168080	20100701	Novel compounds useful as cc chemokine receptor ligands
FRX	Forest Laboratories	20100160323	20100624	Novel piperazine derivatives as inhibitors of stearoyl-coa desaturase
FRX	Forest Laboratories	20100152160	20100617	Novel benzodioxane and benzoxazine derivatives useful as cc chemokine receptor ligands
FRX	Forest Laboratories	20100125056	20100520	Crystalline form of linaclotide
FRX	Forest Laboratories	20100081723	20100401	Memantine for the treatment of childhood behavioral disorders
FRX	Forest Laboratories	20100048726	20100225	Memantine for the treatment of mild and mild to moderate alzheimer's disease
FRX	Forest Laboratories	20100048630	20100225	Methods for treating cns disorders
FRX	Forest Laboratories	20100048629	20100225	Methods for treating neuropathic pain
FRX	Forest Laboratories	20100016334	20100121	Pharmaceutical formulations containing dopamine receptor ligands
FRX	Forest Laboratories	20100010044	20100114	Novel crystalline form of 2-[4-(4-fluoro-benzyl)-piperidine-1-yl]-2-oxo-n-(2-oxo-2,3-dihydro-benzoxazol-6-yl)-acetamide

###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Forest Laboratories Inc. in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Forest Laboratories Inc. with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###